GlaxoSmithKline’s asthma med among top-selling drugs in U.S. – Triangle Business Journal (blog)

GlaxoSmithKline's asthma med among top-selling drugs in U.S.
Triangle Business Journal (blog)
The British drug company, which has its North American headquarters in Research Triangle Park, comes in fifth with asthma medicine Advair Diskus. The rest of the top five: Otsuka Pharmaceuticals' Abilify. AstraZeneca Pharmaceuticals' (NYSE: AZN) Nexium

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.